Backgrounds/Aims: Mirizzi syndrome (MS) is an uncommon complication of cholelithiasis. The aim of this study is to evaluate our 15-year experience in this challenging entity and to propose a new classification for this disease. Methods: A retrospective study including patients diagnosed with Mirizzi syndrome and undergoing surgical procedures for Mirizzi syndrome between January 2000 and October 2015 was conducted. Data collected included clinical, surgical procedure, postoperative morbidity. Patients were evaluated according to the Csendes classification and the proposed system, in which patients were divided into three types and three subtypes. Results: 28 patients were included for analysis. They accounted as the 0.5% of a total of 4853 cholecystectomies performed in the study period. There were 21 women and 7 men. Initial laparotomic approach was performed in 12 patients and in 16 patients laparoscopic procedures were attempted. The procedure was completed in only 6 patients, 5 presenting type I and 1 type II Mirizzi syndrome. Mean postoperative stay was 15±9 days. Postoperative morbidity rate was 28%. Postoperative mortality was none. Conclusions: Laparoscopic surgery for Mirizzi syndrome has been shown succesful only in early stages. A novel classification is proposed, based on the types of common bile duct injuries and in the presence cholecystoenteric fistula. (Ann Hepatobiliary Pancreat Surg 2017;21:67-75)
INTRODUCTION
First described by Kehr in 1905 1 and Ruge in 1908, 2 Mirizzi syndrome or extrinsic biliary compression syndrome, is a rare complication of cholelithiasis. 3 However, it was only in 1948, when Pablo Mirizzi published an article that established the eponym for this syndrome. 4, 5 Mirizzi syndrome is characterised by obstruction of the common bile duct (CBD), secondary to mechanical compression caused by the impaction of one or multiple gallstones in the neck of the gallbladder or cystic duct. 6 The prevalence of this rare complication varies from 0.05 to 3%, 7, 8 and is more frequent in women. Csendes et al., 11 who divided Type II into 3 subtypes (by thirds) based on the extent of bile duct wall involvement.
A fifth type was added in 2007, which refers to any other type of Mirizzi syndrome associated with cholecystoenteric fistula (CEF). 8, 12, 13 Finally, in 2012, Beltrán 14 established a new classification based on a suggestion by Solis-Caxaj, 15 wherein the types of cholecystobiliary fistula are reduced to two, based on whether more or less than 50% of the CBD is affected.
Mirizzi syndrome is surgically treated, and is considered a challenge for all surgerons. As there are no signs or symptoms typical of this entity, and the percentage of patients diagnosed preoperatively varies widely, from 8% to 62.5%. 16 Owing to the high incidence of surgical CBD injuries 14, 17 Hence, the laparoscopic approach is considered controversial, and is only accepted in early stages of Mirizzi syndrome. 18, 19 In this study, we retrospectively assess our experience in the diagnosis and treatment of Mirizzi syndrome. In order to standardize the surgical treatment, we propose a new classification of this syndrome. 
MATERIALS AND METHODS

RESULTS
A total of 28 patients with Mirizzi syndrome were included in this study. Of a total of 4853 cholecystectomies performed between January 2000 and October 2015 at our center, these patients represent a 0.5% incidence. Data from 21 (75%) women and 7 (25%) men was extracted.
The mean age was 64±17 years. A previous history of biliary disease was reported in 21 (75%) patients. Of these, 9 (32%) had presented episodes of biliary colic, 3 (11%) obstructive jaundice, 2 (7%) acute cholecystitis, 3 (11%) cholangitis, 1 (4%) presented with constitutional syndrome, 1 (4%) with gallstone ileus, whereas 3 patients (11%) had asymptomatic cholelithiasis. The median time from onset to surgery in patients who presented previous biliary disease was 4.5 months, with IQR 4.5-7 months.
The most common signs and symptoms at diagnosis were abdominal pain and fever in 12 patients (43%). Laboratory findings and preoperative image diagnosis are shown in Table 2 . Ultrasonpgraphy was performed in all patients, and was diagnostic in 14 of them. Preoperative diagnosis was obtained in 19 patients (68%), and 7 (25%) patients underwent ERCP prior to surgery; 5 patients (18%) were operated in an emergency setting due to a diagnosis of acute cholecystitis, and 23 patients (82%) underwent elective surgery. Laparotomy was performed in 12 patients (43%), and a laparoscopic approach was attempted in 16 (57%). The laparoscopic procedure could be completed in only 6 patients, of which 5 were type I, and only 1 was type II. The reasons for conversion in the remaining 9 cases were the presence of inflammatory mass and fibrosis that prevented the correct identification of structures with- with gallstone ileus, so we first treated the gallbladder ileus, followed by a second session where a laparoscopic cholecystectomy was performed.
A description of surgical procedures according the Csendes classification is shown in Table 2 and Fig. 2 .
There was no postoperative mortality, and the morbidity rate was 28%. Postoperative biliary fistula was reported Two patients were diagnosed with choledocholithiasis after 2 years, and were treated with ERCP.
DISCUSSION
Mirizzi syndrome is produced by an acute or chronic inflammation as a result of the impaction, or one or multiple gallstones, in the Hartman pouch, gallbladder infundibulum, or cystic duct. The pathophysiological sequence to formation of the cholecystobiliary fistula has been described by McSherry et al. 10 and Csendes et al., 13 who also suggested that the appearance of CEF is the next stage in the same disease process. Predisposing factors for the development of this syndrome include the presence of a long cystic duct running parallel to the CBD, or a distal cystic duct insertion into the CBD. 21 Its incidence in our setting was 0.5%, confirming the rarity of this syndrome, and is consistent with previous reports in developed countries. [3] [4] [5] [6] [7] Our results are also consistent with regards to both mean age at presentation (64 years old [53-70 years]), 22 and higher frequency in women (76% of cases). 9 At initial presentation and diagnosis, the most common symptom in our patients was abdominal pain associated with fever, followed by jaundice; 4 patients were asymptomatic at diagnosis.
No sensitive diagnostic tests are currently available for the diagnosis of Mirizzi syndrome. As in other biliary diseases, ultrasound is the first-line diagnostic test, with sensitivity varying from 8.3% to 62.7% 15 (50% in our series).
Ultrasound identifies various characteristic features of
Mirizzi syndrome, such as presence of a small gallbladder, with thin walls containing one or multiple gallstones in the infundibulum, and dilatation of the intra-and extrahepatic bile ducts to the level of the obstruction.
Occasionally, however, the only finding reported is the presence of choledocholithiasis.
The sensitivity of ultrasonography and computed tomography is similar, although the latter is more useful in ruling out neoplastic processes that affect the periportal region. 23 Magnetic resonance cholangiopancreatography (MRCP) is a sensitive technique for detecting gallstones and bile duct stenosis, and can identify dilatation of the intrahepatic bile ducts, the degree of inflammation and presence of fistula, as well as differentiating tumour from inflammatory processes. 24 Although it is a non-invasive, radiation-free test, it is not widely used due to its low availability and high cost.
ERCP is considered the gold standard for the diagnosis of Mirizzi syndrome, 25, 26 with its sensitivity ranging from 55% to 90%. 27 In addition to being a diagnostic procedure, it is also a therapeutic technique that enables extraction of gallstones from the CBD or biliary drainage using stents, allowing for elective surgery to be performed. 28 Nevertheless, it presents some limitations. Fibrosis of the structures or the presence of choledocholithiasis sometimes makes it difficult to access the CBD; moreover, the technique is not free of complications, such as cholangitis or pancreatitis.
As previously noted, the intraoperative diagnosis rate is high in our series, 29 so intraoperative cholangiography plays a fundamental role. This technique provides a definitive diagnosis, including the assessment of the presence and characteristics of potential biliary fistulas, defects in the CBD, and choledocholithiasis. It is extensively used in our hospital, and is systematically performed in patients with complex biliary disease, which explains the limited use of ERCP and MRCP (25% and 11%, respectively).
Based on the Csendes classification, type I in our study accounts for 39% of cases, and types II, III, IV and V for 21%, 14%, 14% and 10%, respectively (Table 2) .
However, the incidence of type I is higher in other published series, such as those presented by Cui et al. 22 and
Lledó et al. 30 (Table 3) . We believe this disparity can be explained because, in our setting, type I is often not iden- no action is subsequently taken on the bile duct. In any case, treatment of the CBD largely depends on the degree to which it is affected.
The postoperative mortality described in various series previously is less than 1%, as against nil in our series.
However, morbidity varies widely, from 5% 27 to 31%; 30 Cui et al. 22 estimate it to be around 9.5% (Table 3 ). We observed only 1 case of biliary fistula that resolved with conservative treatment, and 1 case of biliary stenosis that required surgical intervention. A close relationship exists between Mirizzi syndrome and gallbladder cancer, and between 0% 22 and 28% 33 of patients with a preoperative diagnosis of Mirizzi syndrome are reported to present gallbladder cancer. Both diseases share the same pathophysiological mechanism, namely the presence of gallstones for long durations, resulting in chronic inflammation and inducing damage to the bile duct mucosa.
In conclusion, Mirizzi syndrome today continues to be an entity with a very low incidence, and presents both a diagnostic and therapeutic challenge for surgeons. Our experience highlights the fact that although laparoscopic surgery plays a fundamental role in the treatment of various biliary diseases, its use in this syndrome is relegated to the very early stages. As many surgeons could be involved in treating this disease, this proposed classification could guide the surgical management of this syndrome and improve postoperative outcomes.
